# Obsidio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obsidio

- Industry: Medical Devices & Equipment
- Headquarters: Columbia, US
- Website: www.obsidiomed.com
- Latest round: Seed (Aug 21, 2019)
- Investors on record: 1

## About

Obsidio, Inc. specializes in innovative software solutions tailored for healthcare, finance, and logistics, enhancing operational efficiency and supporting seamless communication across various sectors.Founded in 2018 by Ehsan Jabbarzadeh, Obsidio, Inc. is based in Columbia, US. The company has completed 4 deals, with its most recent funding round being a Grant worth USD 0.230 mn from the National Science Foundation, contributing to the total amount raised of USD 3.000 mn. In August 2022, Boston Scientific Corporation acquired Obsidio, Inc., with financial details undisclosed; this acquisition is expected to have an immaterial impact on Boston Scientific's earnings in 2022.Obsidio, Inc. offers a suite of innovative software solutions that aim to address the needs of various sectors, emphasizing efficiency and user-centric functionality. Their core product line includes advanced software tools and platforms that streamline processes in industries such as healthcare, finance, and logistics. These products are tailored to enhance operational workflows, improve data analysis, and facilitate seamless communication among stakeholders. The end users of these services range from small businesses to large enterprises, each leveraging the company's technology to tackle specific challenges such as resource management, compliance tracking, and customer engagement. The geographical markets for these offerings extend beyond domestic boundaries, targeting clients in North America, Europe, and select regions in Asia, where demand for technological advancements is on the rise.Revenue generation for Obsidio, Inc. is primarily structured around a subscription-based model, enabling clients to access its software services on a recurring basis. This model typically involves tiered pricing plans that cater to businesses of varying sizes and needs, allowing for scalable solutions. Transactions occur directly between the company and its clients, with personalized contracts to ensure alignment with client requirements. The firm’s flagship products include multi-functional platforms that provide comprehensive analytics and reporting capabilities, thereby delivering value that aligns with clients’ operational goals. Partnerships with industry leaders further enhance the company’s reach and solidify its market presence, establishing a dependable revenue stream through ongoing client engagements and service renewals.Obsidio, Inc. has strategic plans for future growth, including the development of new products aimed at enhancing their existing software suite. Specific release dates have not been disclosed. The company is targeting expansion into new geographic markets, particularly in Asia, by the end of 2023. Recent funding from the Grant received in August 2022 will be utilized to support these initiatives, allowing the company to enhance its product offerings and increase market penetration following its acquisition by Boston Scientific Corporation.

## Funding rounds

- Seed, Aug 21, 2019 — Good Growth Capital

## Investors

- Good Growth Capital (https://capitalatlas.ai/funds/good-growth-capital) — Seed